MENU
RCKT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Rocket Pharmaceuticals (RCKT) Earnings Date & Reports

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

RCKT is expected to report earnings to fall 18.40% to -50 cents per share on November 05

Rocket Pharmaceuticals RCKT Stock Earnings Reports
Q3'25
Est.
$-0.51
Q2'25
Missed
by $0.06
Q1'25
Beat
by $0.03
Q4'24
Beat
by $0.10
Q3'24
Beat
by $0.04
The last earnings report on August 07 showed earnings per share of -62 cents, missing the estimate of -56 cents. With 404.40K shares outstanding, the current market capitalization sits at 308.61M.
View a ticker or compare two or three
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RCKT showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a provider of gene therapy services

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
9 Cedarbrook Drive
Phone
+1 609 659-8001
Employees
268
Web
https://www.rocketpharma.com